Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer
Simona Nanni, … , Alfredo Pontecorvi, Antonella Farsetti
Simona Nanni, … , Alfredo Pontecorvi, Antonella Farsetti
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):219-227. https://doi.org/10.1172/JCI15552.
View: Text | PDF
Article Genetics

Signaling through estrogen receptors modulates telomerase activity in human prostate cancer

  • Text
  • PDF
Abstract

Research Article

Authors

Simona Nanni, Michela Narducci, Linda Della Pietra, Fabiola Moretti, Annalisa Grasselli, Piero De Carli, Ada Sacchi, Alfredo Pontecorvi, Antonella Farsetti

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Functional reporter and in vivo chromatin immunoprecipitation assays wit...
Functional reporter and in vivo chromatin immunoprecipitation assays with hTERT promoter in PCa cells. Transient transfections with (a) p1009 or p1009Mut reporters containing wild-type or mutated proximal hTERT-ERE; (b) p1009 reporter alone (–ER), or in combination with expression vectors for ER-α (+ER-α) or ER-β (+ER-β); (c) p1009 or VIT reporters with expression vectors for ER-β (+ER-β) were performed. Values are expressed as fold of hormone induction, calculated as the ratio of normalized luciferase activity (light units per β-galactosidase units per minute per μg of protein) in the presence or absence of E2 (+/– E2). Results represent the average (± SEM) of six independent experiments, each performed in duplicate. Similar results were obtained with a longer hTERT located at –949/–935 (proximal) and at –2757/–2738 (distal) relative to the ATG (data not shown). Formaldehyde cross-linked chromatin from LNCaP and DU145 cells untreated (0’), or treated with E2 (10–7 M) for 45 and 90 minutes (45’ and 90’), or with triiodothyronine (T3 ,10–7 M) for 45 minutes (+) was immunoprecipitated with Ab’s to ER-α (α–ER-α), ER-β (α–ER-β), NF-Y (α NF-Y), or in the absence of Ab’s (no Ab) and analyzed by PCR with primers specific for the hTERT (d) and CycB1 (e) promoters. Input corresponds to nonimmunoprecipitated cross-linked chromatin. Primer position (arrows) on schematic promoters relative to the start site of transcription (+1) and primer migration (*) are indicated.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts